| 상품명칭 |
Tubeimoside A |
| 영문 이름 |
Tubeimoside A;TUBEIMOSIDE 1; TUBEIMOSIDE I; TUBEMOSIDE A; TUBELMOSIDEA; hydroxy-3-methyl-1-oxobutyl)-α-L-arabinopyra; Lobatoside H; nosyl]-β-D-glucopyranosyl]oxy]-2,23-dihydroxy-,28-(O-β-D-xylopyranosyl-(1→3)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-α-L-arabinopyranosyl)ester, intramol. ester, [2β,3β(S),4α]-; (1S,4S,7R,8S,9R,11S,13S,14S,18S,21R,22R,23S,24R,25R,27R,28S,29S,30R,32R,34R,35S,37S,38S,41R,42R,46S,53S,54R,56S,57R)-7,8,18,22,23,24,28,29,35,57-decahydroxy-30,54-bis(hydroxymethyl)-13,18,37,41,42,46,48,48,53,54-decamethyl-56-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}-3,5,10,12,15,26,31,33,55-nonaoxadecacyclo[39.9.3.2~11,14~.1~21,25~.1~34,38~.0~1,46~.0~4,9~.0~27,32~.0~37,42~.0~45,53~]heptapentacont-44-ene-2,16,20-trione (non-preferred name) |
| 분자식 |
C65H102O29 |
| 분자량 |
1347.488 |
| InChI |
InChI=1/C65H102O29/c1-27-45-47(90-51-42(79)36(73)30(70)23-84-51)44(81)53(86-27)91-48-37(74)31(71)24-85-54(48)94-56(82)65-17-15-57(2,3)25-62(65,8)34-12-14-64(10)61(7)20-29(69)50(59(5,26-67)33(61)11-13-63(64,9)60(34,6)16-18-65)93-55-49(40(77)38(75)32(22-66)87-55)92-52-43(80)39(76)41(78)46(89-52)28(68)19-58(4,83)21-35(72)88-45/h12,27,29-33,36-55,66-67,69-71,73-81,83H,11,13-26H2,1-10H3/t27-,29-,30+,31+,32+,33+,36-,37-,38+,39-,40-,41+,42+,43+,44+,45-,46-,47-,48+,49+,50-,51-,52-,53-,54-,55-,58-,59-,60+,61-,62-,63-,64+,65+/m0/s1 |
| cas번호 |
102040-03-9 |
| 분자 구조 |
|
| 밀도 |
1.5g/cm3 |
| 굴절 지수 |
1.638 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
